Form 8-K - Current report:
SEC Accession No. 0001404644-25-000070
Filing Date
2025-06-30
Accepted
2025-06-30 16:02:07
Documents
50
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20250630.htm   iXBRL 8-K 28679
2 EX-99.1 regupdaterelease.htm EX-99.1 29933
3 EX-99.2 a202506_ngnecorporatepre.htm EX-99.2 43393
7 a202506_ngnecorporatepre001.jpg GRAPHIC 103634
8 a202506_ngnecorporatepre002.jpg GRAPHIC 292992
9 a202506_ngnecorporatepre003.jpg GRAPHIC 124041
10 a202506_ngnecorporatepre004.jpg GRAPHIC 59734
11 a202506_ngnecorporatepre005.jpg GRAPHIC 130437
12 a202506_ngnecorporatepre006.jpg GRAPHIC 37907
13 a202506_ngnecorporatepre007.jpg GRAPHIC 120012
14 a202506_ngnecorporatepre008.jpg GRAPHIC 120915
15 a202506_ngnecorporatepre009.jpg GRAPHIC 126592
16 a202506_ngnecorporatepre010.jpg GRAPHIC 35990
17 a202506_ngnecorporatepre011.jpg GRAPHIC 116877
18 a202506_ngnecorporatepre012.jpg GRAPHIC 119840
19 a202506_ngnecorporatepre013.jpg GRAPHIC 128686
20 a202506_ngnecorporatepre014.jpg GRAPHIC 138150
21 a202506_ngnecorporatepre015.jpg GRAPHIC 172363
22 a202506_ngnecorporatepre016.jpg GRAPHIC 129711
23 a202506_ngnecorporatepre017.jpg GRAPHIC 107093
24 a202506_ngnecorporatepre018.jpg GRAPHIC 94131
25 a202506_ngnecorporatepre019.jpg GRAPHIC 122251
26 a202506_ngnecorporatepre020.jpg GRAPHIC 120967
27 a202506_ngnecorporatepre021.jpg GRAPHIC 119239
28 a202506_ngnecorporatepre022.jpg GRAPHIC 76751
29 a202506_ngnecorporatepre023.jpg GRAPHIC 74237
30 a202506_ngnecorporatepre024.jpg GRAPHIC 120499
31 a202506_ngnecorporatepre025.jpg GRAPHIC 103532
32 a202506_ngnecorporatepre026.jpg GRAPHIC 118030
33 a202506_ngnecorporatepre027.jpg GRAPHIC 33822
34 a202506_ngnecorporatepre028.jpg GRAPHIC 87699
35 a202506_ngnecorporatepre029.jpg GRAPHIC 26267
36 a202506_ngnecorporatepre030.jpg GRAPHIC 143302
37 a202506_ngnecorporatepre031.jpg GRAPHIC 134778
38 a202506_ngnecorporatepre032.jpg GRAPHIC 120513
39 a202506_ngnecorporatepre033.jpg GRAPHIC 90307
40 a202506_ngnecorporatepre034.jpg GRAPHIC 90505
41 a202506_ngnecorporatepre035.jpg GRAPHIC 82808
42 image_0a.jpg GRAPHIC 3474
  Complete submission text file 0001404644-25-000070.txt   5523140

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250630.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250630_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250630_pre.xml EX-101.PRE 13050
52 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250630_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 251091905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)